substance p has been researched along with Zollinger-Ellison Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rehfeld, JF | 1 |
| Champetier, P; Chayvialle, JA; Forichon, J; Partensky, C; Sassolas, G; Souquet, JC | 1 |
2 other study(ies) available for substance p and Zollinger-Ellison Syndrome
| Article | Year |
|---|---|
Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Topics: Adenoma, Islet Cell; Carcinoid Tumor; Cholecystokinin; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Insulin; Intestinal Neoplasms; Motilin; Pancreatic Hormones; Pancreatic Neoplasms; Pancreatic Polypeptide; Radioimmunoassay; Secretin; Somatostatin; Substance P; Vasoactive Intestinal Peptide; Zollinger-Ellison Syndrome | 1979 |
Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome.
Topics: Adult; Aged; Carcinoid Tumor; Female; Gastric Juice; Gastrins; Glucagonoma; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatin; Substance P; Zollinger-Ellison Syndrome | 1987 |